Peter Powchik Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter Powchik.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter Powchik. Peter Powchik is SVP Clin Devel & Reg Affairs in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Clinical Development in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Clinical Development & Reg in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, Clinical Development in REGENERON PHARMACEUTICALS INC ($REGN).

Peter Powchik in REGENERON PHARMACEUTICALS, INC.

Trading Symbol: REGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Powchik: SVP Clin Devel & Reg Affairs, SVP Clinical Development & Reg, SVP Clinical Development, SVP, Clinical Development
Holdings: 2,459 shares
Current Value: $879,560
Latest Transaction: Dec 19 2016
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter Powchik in REGENERON PHARMACEUTICALS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 19 2016	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	381.92	5,000	1,909,600	5,000
Dec 19 2016	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Gift	G	0.00	2,459	0	2,459	0 to 2.5 K
Dec 19 2016	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Gift	G	0.00	2,459	0	2,459	0 to 2.5 K
Dec 19 2016	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Gift	G	0.00	2,459	0	0	2.5 K to 0 (-100.00 %)
Dec 19 2016	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Gift	G	0.00	2,459	0	2,459	4.9 K to 2.5 K (-50.00 %)
Dec 18 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	555.67	25,000	13,891,750	25,000
Dec 18 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	52.03	1,921	99,950	0
Dec 18 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	52.03	1,921	99,950	17,742	15.8 K to 17.7 K (+12.14 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	270.43	10,000	2,704,300	30,000
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	179.13	14,625	2,619,776	29,250
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	52.03	8,000	416,240	6,079
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	52.03	23,000	1,196,690	14,079
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	30.63	4,736	145,064	0
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	578.63	1,500	867,945	15,821	17.3 K to 15.8 K (-8.66 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	577.75	2,258	1,304,560	17,321	19.6 K to 17.3 K (-11.53 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	576.65	2,004	1,155,607	19,579	21.6 K to 19.6 K (-9.29 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	575.47	700	402,829	21,583	22.3 K to 21.6 K (-3.14 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	574.75	900	517,275	22,283	23.2 K to 22.3 K (-3.88 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	573.64	2,717	1,558,580	23,183	25.9 K to 23.2 K (-10.49 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	572.60	2,800	1,603,280	25,900	28.7 K to 25.9 K (-9.76 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	571.54	5,598	3,199,481	28,700	34.3 K to 28.7 K (-16.32 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	570.63	3,603	2,055,980	34,298	37.9 K to 34.3 K (-9.51 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	569.63	1,405	800,330	37,901	39.3 K to 37.9 K (-3.57 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	2,146	1,243,285	39,306	41.5 K to 39.3 K (-5.18 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	250	144,838	41,452	41.7 K to 41.5 K (-0.60 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	30.63	4,736	145,064	41,702	37 K to 41.7 K (+12.81 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	3,755	2,175,459	36,966	40.7 K to 37 K (-9.22 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	718	415,973	40,721	41.4 K to 40.7 K (-1.73 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	52.03	8,000	416,240	41,439	33.4 K to 41.4 K (+23.92 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	10,795	6,254,083	33,439	44.2 K to 33.4 K (-24.40 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	2,065	1,196,358	44,234	46.3 K to 44.2 K (-4.46 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	52.03	23,000	1,196,690	46,299	23.3 K to 46.3 K (+98.72 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	5,210	3,018,414	23,299	28.5 K to 23.3 K (-18.27 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	4,521	2,619,241	28,509	33 K to 28.5 K (-13.69 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	179.13	14,625	2,619,776	33,030	18.4 K to 33 K (+79.46 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	2,749	1,592,633	18,405	21.2 K to 18.4 K (-13.00 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	579.35	4,667	2,703,826	21,154	25.8 K to 21.2 K (-18.07 %)
Aug 17 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	270.43	10,000	2,704,300	25,821	15.8 K to 25.8 K (+63.21 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	52.03	25,000	1,300,750	37,079
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	418.40	300	125,520	10,711	11 K to 10.7 K (-2.72 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	417.44	1,000	417,440	11,011	12 K to 11 K (-8.33 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	416.75	900	375,075	12,011	12.9 K to 12 K (-6.97 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	415.20	1,642	681,758	12,911	14.6 K to 12.9 K (-11.28 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	414.07	2,758	1,142,005	14,553	17.3 K to 14.6 K (-15.93 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	412.81	1,700	701,777	17,311	19 K to 17.3 K (-8.94 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	411.99	1,122	462,253	19,011	20.1 K to 19 K (-5.57 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	410.99	1,400	575,386	20,133	21.5 K to 20.1 K (-6.50 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	412.78	11,027	4,551,725	21,533	32.6 K to 21.5 K (-33.87 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	412.78	3,151	1,300,670	32,560	35.7 K to 32.6 K (-8.82 %)
Jan 05 2015	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	52.03	25,000	1,300,750	35,711	10.7 K to 35.7 K (+233.40 %)
Dec 22 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	30.63	3,264	99,976	0
Dec 22 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	30.63	3,264	99,976	10,711	7.4 K to 10.7 K (+43.83 %)
Dec 18 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	399.66	34,000	13,588,440	34,000
Dec 18 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	52.03	48,000	2,497,440	62,079
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	30.63	48,000	1,470,240	4,736
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	277.50	100	27,750	25,447	25.5 K to 25.4 K (-0.39 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	276.75	1,296	358,668	25,547	26.8 K to 25.5 K (-4.83 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	276.04	6,893	1,902,744	26,843	33.7 K to 26.8 K (-20.43 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	274.69	3,777	1,037,504	33,736	37.5 K to 33.7 K (-10.07 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	273.77	5,602	1,533,660	37,513	43.1 K to 37.5 K (-12.99 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	272.88	3,000	818,640	43,115	46.1 K to 43.1 K (-6.51 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	276.09	22,007	6,075,913	46,115	68.1 K to 46.1 K (-32.31 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	276.09	5,325	1,470,179	68,122	73.4 K to 68.1 K (-7.25 %)
Jan 03 2014	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	30.63	48,000	1,470,240	73,447	25.4 K to 73.4 K (+188.63 %)
Dec 26 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	21.25	4,705	99,981	0
Dec 26 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	21.25	4,705	99,981	25,447	20.7 K to 25.4 K (+22.68 %)
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	21.25	295	6,269	0
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	271.09	133	36,055	20,742	20.9 K to 20.7 K (-0.64 %)
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	264.86	139	36,816	20,875	21 K to 20.9 K (-0.66 %)
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	264.86	23	6,092	21,014	21 K to 21 K (-0.11 %)
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	21.25	295	6,269	21,037	20.7 K to 21 K (+1.42 %)
Dec 20 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	270.20	9,000	2,431,800	20,742	29.7 K to 20.7 K (-30.26 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	270.43	40,000	10,817,200	40,000
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	179.13	14,625	2,619,776	43,875
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	52.03	8,000	416,240	14,079
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	30.63	8,000	245,040	52,736
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	A	30.63	48,000	1,470,240	60,736
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	270.00	8	2,160	29,742	29.8 K to 29.7 K (-0.03 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	3,662	998,737	29,750	33.4 K to 29.8 K (-10.96 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	898	244,912	33,412	34.3 K to 33.4 K (-2.62 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	30.63	8,000	245,040	34,310	26.3 K to 34.3 K (+30.41 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	2,588	705,825	26,310	28.9 K to 26.3 K (-8.96 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	9,605	2,619,572	28,898	38.5 K to 28.9 K (-24.95 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	179.13	14,625	2,619,776	38,503	23.9 K to 38.5 K (+61.25 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	3,338	910,373	23,878	27.2 K to 23.9 K (-12.26 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	272.73	1,526	416,186	27,216	28.7 K to 27.2 K (-5.31 %)
Dec 17 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	52.03	8,000	416,240	28,742	20.7 K to 28.7 K (+38.57 %)
Jan 10 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	21.25	752	15,980	4,705
Jan 10 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	16.80	5,000	84,000	0
Jan 10 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	16.80	5,000	84,000	20,742	15.7 K to 20.7 K (+31.76 %)
Jan 10 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	21.25	752	15,980	15,742	15 K to 15.7 K (+5.02 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	21.25	30,000	637,500	295
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	183.10	4,300	787,330	14,990	19.3 K to 15 K (-22.29 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	182.29	2,300	419,267	19,290	21.6 K to 19.3 K (-10.65 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	181.51	6,200	1,125,362	21,590	27.8 K to 21.6 K (-22.31 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	180.83	786	142,132	27,790	28.6 K to 27.8 K (-2.75 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	177.82	12,830	2,281,431	28,576	41.4 K to 28.6 K (-30.99 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	177.82	3,584	637,307	41,406	45 K to 41.4 K (-7.97 %)
Jan 04 2013	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	21.25	30,000	637,500	44,990	15 K to 45 K (+200.13 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	52.03	8,000	416,240	22,079
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	30.63	16,000	490,080	12,736
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	M	21.25	14,248	302,770	30,295
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	171.11	2,000	342,220	14,990	17 K to 15 K (-11.77 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	170.44	4,623	787,944	16,990	21.6 K to 17 K (-21.39 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	183.13	500	91,565	21,613	22.1 K to 21.6 K (-2.26 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	181.25	100	18,125	22,113	22.2 K to 22.1 K (-0.45 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	180.62	1,256	226,859	22,213	23.5 K to 22.2 K (-5.35 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	179.56	1,000	179,560	23,469	24.5 K to 23.5 K (-4.09 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	178.33	2,200	392,326	24,469	26.7 K to 24.5 K (-8.25 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	177.52	4,266	757,300	26,669	30.9 K to 26.7 K (-13.79 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Sell	S	176.79	1,034	182,801	30,935	32 K to 30.9 K (-3.23 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	5,783	1,032,959	31,969	37.8 K to 32 K (-15.32 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	1,694	302,582	37,752	39.4 K to 37.8 K (-4.29 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	21.25	14,248	302,770	39,446	25.2 K to 39.4 K (+56.54 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	6,107	1,090,832	25,198	31.3 K to 25.2 K (-19.51 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	2,743	489,955	31,305	34 K to 31.3 K (-8.06 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	30.63	16,000	490,080	34,048	18 K to 34 K (+88.65 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	2,612	466,555	18,048	20.7 K to 18 K (-12.64 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Payment of Exercise	F	178.62	2,330	416,185	20,660	23 K to 20.7 K (-10.13 %)
Dec 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Buy	M	52.03	8,000	416,240	22,990	15 K to 23 K (+53.37 %)
Dec 17 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	A	179.13	58,500	10,479,105	58,500
Dec 17 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clin Devel & Re ...	Option Exercise	A	21.25	30,000	637,500	44,543
Nov 09 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	139.05	900	125,145	14,990	15.9 K to 15 K (-5.66 %)
Nov 09 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	138.59	14,244	1,974,076	15,890	30.1 K to 15.9 K (-47.27 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	16.80	15,000	252,000	0
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	148.00	1,000	148,000	30,134	31.1 K to 30.1 K (-3.21 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	147.16	3,200	470,912	31,134	34.3 K to 31.1 K (-9.32 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	146.89	2,977	437,292	34,334	37.3 K to 34.3 K (-7.98 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	148.78	6,130	912,021	37,311	43.4 K to 37.3 K (-14.11 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	148.78	1,693	251,885	43,441	45.1 K to 43.4 K (-3.75 %)
Sep 20 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	16.80	15,000	252,000	45,134	30.1 K to 45.1 K (+49.78 %)
Aug 02 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	21.92	4,562	99,999	0
Aug 02 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	15.64	10,428	163,094	0
Aug 02 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	15.64	10,428	163,094	30,134	19.7 K to 30.1 K (+52.92 %)
Aug 02 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	21.92	4,562	99,999	19,706	15.1 K to 19.7 K (+30.12 %)
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	16.80	15,000	252,000	15,000
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	131.07	2,500	327,675	15,144	17.6 K to 15.1 K (-14.17 %)
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	130.40	4,519	589,278	17,644	22.2 K to 17.6 K (-20.39 %)
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	126.76	5,994	759,799	22,163	28.2 K to 22.2 K (-21.29 %)
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Payment of Exercise	F	126.76	1,987	251,872	28,157	30.1 K to 28.2 K (-6.59 %)
Jul 27 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Buy	M	16.80	15,000	252,000	30,144	15.1 K to 30.1 K (+99.05 %)
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	21.92	25,438	557,601	0
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	20.32	20,000	406,400	0
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	16.80	15,000	252,000	30,000
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Option Exercise	M	15.64	49,428	773,054	0
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	98.05	1,200	117,660	15,144	16.3 K to 15.1 K (-7.34 %)
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	97.58	9,600	936,768	16,344	25.9 K to 16.3 K (-37.00 %)
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	96.45	23,454	2,262,138	25,944	49.4 K to 25.9 K (-47.48 %)
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	95.46	10,800	1,030,968	49,398	60.2 K to 49.4 K (-17.94 %)
Feb 23 2012	REGN	REGENERON PHARMACE ...	Powchik Peter	SVP Clinical Develo ...	Sell	S	94.71	4,200	397,782	60,198	64.4 K to 60.2 K (-6.52 %)

Page: 1 2 next >